Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 697 $ 434
Marketable debt securities, available for sale 840 926
Escrow receivable 4,812 4,812
Accounts receivable, net 1,213 2,010
Inventory 1,703 1,459
Prepaid expenses and other current assets 240 304
Total current assets 9,505 9,945
Property, plant and equipment, net of accumulated depreciation of $6,295 and $6,252, respectively 2,363 2,329
TOTAL ASSETS 11,868 12,274
Current liabilities    
Accounts payable 695 432
Accrued advertising and other allowances 92 92
Other current liabilities 338 409
Total current liabilities 1,125 933
Non-current liabilities:    
Deferred revenue, net of current portion 112 110
Total non-current liabilities 112 110
Total liabilities 1,237 1,043
COMMITMENTS AND CONTINGENCIES
Stockholders' equity    
Preferred stock authorized 1,000,000, $.0005 par value, no shares issued
Common stock authorized 50,000,000, $.0005 par value, issued 28,233,961 and 28,225,615 shares, respectively 14 14
Additional paid-in capital 60,413 60,215
Accumulated deficit (2,315) (1,506)
Treasury stock, at cost, 16,652,022 and 16,652,022 shares (47,490) (47,490)
Accumulated comprehensive income (loss) 9 (2)
Total stockholders' equity 10,631 11,231
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 11,868 $ 12,274